Home RxNorm 1875542 avelumab 200 MG in 10 ML Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1875542
RxNorm name avelumab 200 MG in 10 ML Injection
Display name avelumab 200 MG in 10 ML Injection
Full name avelumab 200 MG in 10 ML Injection
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:39:00 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761049 Bavencio avelumab 351(a) Rx 2026-08-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 5cd725a1-2fa4-408a-a651-57a7b84b2118 avelumab 200 MG in 10 ML Injection [PSN] · 10 ML avelumab 20 MG/ML Injection [SCD] 2 23 These highlights do not include all the information needed to use BAVENCIO safely and effectively. See full prescribing information for BAVENCIO. BAVENCIO ® (avelumab) injection, for intravenous use Initial U.S. Approval: 2017 20250613